Silvana Elba - Saverio de Bellis
Silvana Elba - Saverio de Bellis
Silvana Elba - Saverio de Bellis
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
C U R R I C U L U M V I T A E<br />
INFORMAZIONI PERSONALI<br />
Nome e Cognome <strong>Silvana</strong> <strong>Elba</strong><br />
Data di nascita 24-4-1957<br />
Qualifica Dirigente medico<br />
Amministrazione I.R.C.C.S. S. <strong>de</strong> <strong>Bellis</strong> Castellana Grotte<br />
Incarico attuale Dirigente medico presso la gastroenterologia I<br />
Telefono ufficio 080/4994293<br />
Pagina 1 - Curriculum vitae di<br />
[ ELBA SILVANA ]<br />
Fax Ufficio 080/4994273<br />
E-mail Istituzionale <strong>Silvana</strong>.elba@irccs<strong>de</strong>bellis.it<br />
TITOLI DI STUDIO PROFESSIONALI<br />
ED ESPERIENZE LAVORATIVE<br />
Titoli di studio: Laurea in medicina e chirurgia<br />
Capacità linguistiche: LINGUA Lettura Scrittura Espressione orale<br />
Inglese Livello buono Livello buono Livello discreto<br />
Uso <strong>de</strong>lle Tecnologie: uso eccellente <strong>de</strong>ll’ecografia in epato-gastroenterologia<br />
Esperienze Professionali (Incarichi<br />
ricoperti)<br />
ALTRO (Partecipazione a<br />
Convegni e Seminari,<br />
Pubblicazioni, collaborazioni a<br />
riviste ed ogni altra informazione<br />
che il dirigente ritiene di dover<br />
pubblicare)<br />
Responsabile <strong>de</strong>lla struttura semplice “Ecografia diagnostica ed interventistica in campo<br />
epatologico e gastroenterologico”<br />
Corso avanzato “le terapie ecoguidate” Bologna 1990<br />
Corso avanzato di ecografia interventistica Riccione 1990<br />
Corso avanzato di ecografia addominale Arezzo 2001<br />
Corso di aggiornamento sulle terapie loco-regionali <strong>de</strong>i tumori <strong>de</strong>l fegato Bologna 2001<br />
Corso di ecografia in gastroenterologia Piacenza 2004<br />
Corso di ecografia ed ecointerventistica in epatologia Ravello 2004<br />
Corso di ecografia <strong>de</strong>lle malattie intestinali Milano-Crema 2008<br />
L’elastosonografia Roma 2009<br />
Corso di Inglese scientifico Castellana Grotte 2011.<br />
Nel 2011 ha ottenuto 69 crediti ECM.<br />
Ha partecipato alla stesura di numerose pubblicazioni in campo epatologico, tra i lavori<br />
principali:<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Risk factors in <strong>de</strong>velopment of HCC in cirrhotic patients”<br />
Ital J Gastroenterol, 18(3): 171, 1986.<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Duo<strong>de</strong>nal ulcer relapse after maintenance therapy: 6 months followup”<br />
Dig. Dis. And Sci. Vol. 31, 10 (1986), Sup. 48S.<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Ca 19-9 and CEA in diagnosis of HCC: a Bayesian approach”.<br />
Dig. Dis. And Sci. Vol. 31, 10 (1986), Sup. 87S.<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Ca 19-9 and Cea in <strong>de</strong>tecting HCC in cirrhotic patients: a Bayesian<br />
analysis”<br />
J. Hepatol. Sup. 1, Vol 3, (1986): S 139.<br />
Aggiornato al 8 febbraio 2013
Pagina 2 - Curriculum vitae di<br />
[ ELBA SILVANA ]<br />
R. Cozzolongo, G. Leandro, S. <strong>Elba</strong>, OG Manghisi “The hepatocellular carcinoma in cirrhotic<br />
patients: a prospective study”<br />
Ital. J. Gastroenterol 6 (21): 371, 1989.<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Alfa-fetoprotein, TPA and ferritin in diagnosing primary hepatocellular<br />
carcinoma in patients with liver cirrhosis”<br />
J. cancer Res Clin Oncol 115: 276-278 (1989).<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Do Ca 19-9 and TPA play a minor role as compared to AFP in<br />
diagnosing HCC ?)<br />
Oncology 46: 381-385 (1989).<br />
G. Leandro, R. Cozzolongo, S. <strong>Elba</strong> “Are serum CEA and CA 19-9 useful tests in diagnosing<br />
HCC in cirrhotic patients ?”<br />
J. Exp. Cancer. Res., 9, 3 (1990).<br />
G. Leandro, S. <strong>Elba</strong> et Al. “Hepatocellular carcinoma in cirrhotic patients: role of hepatitis B<br />
Virus”<br />
Ital J gastroenterol 22: 66-69 (1990).<br />
S. <strong>Elba</strong> et Al “L’alcolizzazione percutanea ecoguidata <strong>de</strong>ll’epatocarcinoma (HCC). Esperienze<br />
iniziali” Giornale Italiano di Ultrasonologia Vol1, 3: 179-180 (1990).<br />
S. <strong>Elba</strong> et Al. “Efficacy of endocrine therapy on non resectable primary HCC”<br />
Ital J gastroenterolo 22: 320 (1990).<br />
C. Fabbris, D. Basso, G. Leandro, T. Meggiato S. <strong>Elba</strong> et Al. “Serum Ca19-9 and AFP levels in<br />
primary HCC and Liver Cirrhosis”<br />
Cancer, vol 68, 8: 1795-1798 (1991)<br />
The MICOL GROUP “Prevalence of gallstone disease in 18 Italian population samples: first<br />
result from the Micol study”<br />
Dal libro “Recent advances in the epi<strong>de</strong>miology and prevention of gallstone disease”, pag 37-44,<br />
KLUWER ACADEMIC PUBLISHERS (1991)<br />
D. Festi and the MICOL GROUP “The Italian multicenter study on epi<strong>de</strong>miology and prevention<br />
of cholelithiasis (MICOL): ultrasonographic standardization”<br />
Dal libro “Recent advances in the epi<strong>de</strong>miology and prevention of gallstone disease”, pag. 29-35<br />
KLUMER ACADEMIC PUBLISHERS (1991).<br />
R. Cuppone, S. <strong>Elba</strong> et Al. “Analysis of aetiologic factors of chronic liver disease in southern<br />
Italy”<br />
Ital J gastroenterol 25: 454 (1993)<br />
S. <strong>Elba</strong> et Al. “Randomized controlled trial of Tamoxifen vs Placebo in inoperable HCC”<br />
Ital J Gastroenterol 26: 66-68 (1994).<br />
G. Miscigna, C. Leoci, S. <strong>Elba</strong> et Al. “The epi<strong>de</strong>miology of cholelithiasis in southern italy”<br />
European Journal of Gastroenterology and Hepatology 6: 937-941 (1994)<br />
G. Misciagna, S. <strong>Elba</strong> et Al. “Epi<strong>de</strong>miology of cholelithiasis in southern Italy. Part II: risk factors”<br />
European Journal of Gastroenterology and Hepatology 8: 585-593 (1996)<br />
CLIP GROUP “Tamoxifen in treatment of HCC: a randomized controlled trial”<br />
Lancet 352, 9121, pag. 17-20 (1998).<br />
CLIP GROUP “A new prognostic system for HCC: a retrospective study of 435 patients”<br />
Hepatology 28: 751-755 (1998)<br />
EPIDEMIOLOGY GROUP “Characteristics of hepatocellular carcinoma in Italy”<br />
Journal of Hepatology 29: 944-952 (1998).<br />
M Correale, S. <strong>Elba</strong> et Al. “Serum 90K/MAC-2Bp glycoprotein levels in HCC and cirrhosis”<br />
Anticancer Research 19: 3469-3472 (1999)<br />
CLIP GROUP “Prognostic validation of the CLIP score: a new prognostic system for patients<br />
with cirrhosis and HCC”<br />
Hepatology 31: 840-845 (2000).<br />
AOsella, S. <strong>Elba</strong> et Al. “Hepatitis C Virus genotypes and risk of cirrhosis in southern Italy”<br />
Clinical Infectious Diseases 33: 70-75 (2001).<br />
P.A. Iacovazzi, S. <strong>Elba</strong> et Al. “Serum 90K/MAC-2BP Glycoprotein in patients with Liver Cirrhosis<br />
and HCC: a comparison with AFP”<br />
Clin Chem Lab Med 39 (10): 961-965 (2001).<br />
S. <strong>Elba</strong> et Al. “Main characteristics of hepatocellular carcinoma and cirrhosis and therapeutic<br />
approaches”<br />
Current Pharmaceutical Designa 8: 1007-1011 (2002).<br />
F. Perrone; <strong>Silvana</strong> <strong>Elba</strong> et Al “Tamoxipen in the treatment of HCC: a 5-year results of the CLIP-<br />
1 multicentre randomized controlled trial”.<br />
Current Pharmaceutical Designa 8: 1013-1019 (2002).<br />
Aggiornato al 8 febbraio 2013
Pagina 3 - Curriculum vitae di<br />
[ ELBA SILVANA ]<br />
C. Clemente, S. <strong>Elba</strong> et Al. “Oxidant-antioxidant status in child-pugh class A cirrhotics with HCC”<br />
Digestive and Liver Disease 35: S80 (2003).<br />
PA. Iacovazzi, S. <strong>Elba</strong> et Al. “Are 90K/MAC-2BP serum levels correlated with poor prognosis in<br />
HCC patients? Preliminary results”<br />
The International Journal of Biological Markers, vol 18: 192-196 (2003).<br />
C Clemente, S. <strong>Elba</strong> et Al. “Manganese superoxi<strong>de</strong> dismutase activity and inci<strong>de</strong>nce of HCC in<br />
patients with Child-Pug class A liver cirrhosis: a 7-year follow-up study”<br />
Liver International ISSN 1478-3223 (2007).<br />
R. Cozzolongo, A.R. Osella, S. <strong>Elba</strong> et Al. “Epi<strong>de</strong>miology of HCV Infection in the general<br />
population: a survey in a southern italian town”<br />
The America J of Gastroenterol (2009).<br />
Aggiornato al 8 febbraio 2013